BUSCOPAN

Serial Number 79236482
Registration 5853766
700

Registration Progress

Application Filed
Jun 12, 2018
Under Examination
Approved for Publication
Jun 5, 2019
Published for Opposition
Jun 25, 2019
Registered
Sep 10, 2019

Attorney Assistance

Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20190910) (Grace Period Filing)
Due: Mar 10, 2026 Grace Period - 78 days
Original deadline was Sep 10, 2025 (overdue)

Trademark Image

BUSCOPAN

Basic Information

Serial Number
79236482
Registration Number
5853766
Filing Date
June 12, 2018
Registration Date
September 10, 2019
Published for Opposition
June 25, 2019
Drawing Code
5000

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 10, 2019
Registration
Registered
Classes
005

Rights Holder

A. NATTERMANN & Cie GMBH

99
Address
Brüningstrasse 50
65929 Frankfurt am Main
DE

Ownership History

Sanofi-Aventis Deutschland GmbH

Original Applicant
27
DE

Sanofi-Aventis Deutschland GmbH

Owner at Publication
27
DE

Sanofi-Aventis Deutschland GmbH

Original Registrant
27
DE

A. NATTERMANN & Cie GMBH

New Owner After Registration #1
99
DE

USPTO Deadlines

Next Deadline
In Grace Period
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20190910)
Due Date
September 10, 2025
Grace Period Ends
March 10, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

38 events
Date Code Type Description Documents
Mar 3, 2023 CHLD M CHANGE OF OWNER RECEIVED FROM IB Loading...
Feb 14, 2023 RNWL P INTERNATIONAL REGISTRATION RENEWED Loading...
Feb 7, 2020 FINV P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Jan 24, 2020 INNT P TOTAL INVALIDATION PROCESSED BY THE IB Loading...
Jan 9, 2020 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Jan 9, 2020 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Jan 9, 2020 FIMP P FINAL DISPOSITION PROCESSED Loading...
Jan 8, 2020 CORV 1 REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED Loading...
Dec 10, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 10, 2019 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Sep 10, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 12, 2019 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Jun 25, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 5, 2019 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Jun 5, 2019 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Jun 5, 2019 NPUB O NOTICE OF PUBLICATION Loading...
May 17, 2019 ALIE A ASSIGNED TO LIE Loading...
May 3, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 18, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 17, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 17, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 18, 2019 CNRT O NON-FINAL ACTION MAILED Loading...
Jan 17, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 16, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 15, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 15, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 11, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 11, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 31, 2018 RFNT P REFUSAL PROCESSED BY IB Loading...
Aug 8, 2018 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Aug 8, 2018 RFRR P REFUSAL PROCESSED BY MPU Loading...
Jul 27, 2018 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Jul 26, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 24, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 24, 2018 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jul 18, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 16, 2018 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Jul 12, 2018 SDRC M SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Loading...

Detailed Classifications

Class 005
Medicines, namely, antispasmodics, anticholinergics, analgesics, antacids, antiflatulents, antiulcerants
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005